United States News All stories

Ainos (NASDAQ:AIMD) reported a pivotal fiscal year 2025, characterized by a roughly 499% surge in revenue and a successful transition into high-volume industrial markets.

Tempest (NASDAQ:TPST) announced a significant shift in its corporate trajectory on March 30, 2026, reporting year-end 2025 financial results alongside a strategic move toward partner-funded development.

Oil markets remained on edge Monday, with Brent crude holding near $115 a barrel, as President Donald Trump indicated a potential diplomatic breakthrough in the Middle East while simultaneously threatening military strikes against Iran’s critical energy infrastructure.

Biogen (NASDAQ:BIIB) said the FDA approved a higher-dose regimen of its SPINRAZA (nusinersen) therapy for patients with spinal muscular atrophy (SMA).

Vor Bio (NASDAQ:VOR) has secured a $75 million private placement with TCGX, a transaction executed on March 27, 2026, that significantly bolsters the company's balance sheet.

Eikon Therapeutics (NASDAQ:EIKN), a clinical-stage biotechnology company focused on developing novel medicines through advanced imaging and machine learning platforms, reported corporate and clinical updates on March 30, 2026, alongside its full-year 2025 financial results.

Functional Brands (NASDAQ:MEHA), a leading developer and manufacturer of functional health and wellness products, today announced its financial results for the fourth quarter and full year ended December 31, 2025.

Rezolve Ai (NASDAQ:RZLV), a global leader in AI-powered conversational commerce and retail engagement, today announced its financial results for the full year ended December 31, 2025.

Uber Technologies (NYSE:UBER) today announced a definitive agreement to acquire Blacklane, a premier global chauffeur service, marking a significant escalation in Uber’s strategy to dominate the high-margin luxury and corporate travel segments

Soluna Holdings (NASDAQ:SLNH), a specialized developer of green data centers for intensive computing applications such as Bitcoin mining and artificial intelligence, today announced its financial results for the fourth quarter and full year ended December 31, 2025.

Terrestrial Energy (NASDAQ:IMSR), a developer of Generation IV advanced nuclear technology, today announced its financial results and program milestones for the fourth quarter and full year ended December 31, 2025.

Veradermics (NYSE:MANE), a late-clinical stage biopharmaceutical firm specializing in aesthetic and dermatological therapeutics, today announced its financial results for the fourth quarter and full year ended December 31, 2025.

USA Rare Earth (NASDAQ:USAR) reported a transformative shift in its financial position and operational footprint for the full year 2025, underpinned by a massive capital injection that establishes the company as a primary contender in the race to build a non-Chinese permanent magnet supply chain.

Connect Biopharma Holdings (NASDAQ:CNTB), a clinical-stage biopharmaceutical company focused on chronic inflammatory diseases, today reported positive topline preliminary results from its Phase 1 clinical pharmacology study (CBP-201-105) evaluating an intravenous (IV) formulation of rademikibart.

Boardwalk Pipelines (NYSE:SR) announced today that it has entered into a definitive agreement to acquire Spire Marketing from Spire.

United Therapeutics (NASDAQ:UTHR), a public benefit corporation, today announced that its pivotal TETON-1 study evaluating nebulized Tyvaso® (treprostinil) for the treatment of idiopathic pulmonary fibrosis (IPF) met its primary efficacy endpoint.

Neumora Therapeutics (NASDAQ:NMRA), a clinical-stage biotechnology company pioneering precision medicines for brain diseases, today announced its financial results for the fourth quarter and full year ended December 31, 2025.

GSK (NYSE:GSK) today announced that China’s National Medical Products Administration (NMPA) has granted approval for Exdensur (depemokimab) as an add-on maintenance treatment for severe asthma characterized by an eosinophilic phenotype.

Sysco (NYSE:SYY), North America’s largest foodservice distributor, announced an agreement to acquire Jetro Restaurant Depot, a leading cash-and-carry wholesaler serving independent restaurants and foodservice operators, for approximately $29.1 billion in a combination of cash and stock.

Zymeworks (NASDAQ:ZYME), a clinical-stage biotechnology company developing multifunctional biotherapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to ZW191 for the treatment of patients with advanced or metastatic platinum-resistant ovarian cancer (PROC).

Leidos (NYSE:LDOS), a Fortune 500 innovation leader in defense, aviation, and information technology, announced today the successful completion of its acquisition of ENTRUST Solutions Group for approximately $2.4 billion.

IDEAYA Biosciences (NASDAQ:IDYA), a leading precision medicine oncology company, today announced the first-patient-in (FPI) for its Phase 1 clinical trial evaluating the combination of IDE849 and IDE161.

NANOBIOTIX (NASDAQ:NBTX), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches, today announced promising initial data from the Phase 2 CONVERGE study evaluating its lead candidate, JNJ-1900 (NBTXR3), in patients with stage 3 inoperable non-small cell lung cancer (NSCLC).

Bitdeer Technologies Group (NASDAQ:BTDR), a global leader in advanced computing and blockchain infrastructure, announced today that its subsidiary, Tydal Data Center AS (TDC), has officially engaged Data Center Installations AS (DCI) to develop a state-of-the-art 180 MW artificial intelligence data center in Tydal, Norway.